Overproduction, purification, and biochemical characterization of the dual specificity H1 protein phosphatase encoded by variola major virus

Protein Expression and Purification

Volumn 50, Issue 1, 2006, Pages 31-36

  Tropea, Joseph E ^a   Phan, Jason ^a   Waugh, David S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dual specificity phosphatase; H1 phosphatase; H1L; Smallpox; Variola major

Indexed keywords

ALCOHOL DERIVATIVE; DIMETHYL SULFOXIDE; MACROGOL DERIVATIVE; NITROPHENOL; NITROPHENYL PHOSPHATE; ORGANOPHOSPHORUS COMPOUND; PROTEIN TYROSINE PHOSPHATASE; VH1 PROTEIN, VIRUS; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; ENZYME ACTIVATION; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; KINETICS; MOLECULAR CLONING; MOLECULAR GENETICS; PH; SMALLPOX VIRUS;

ALCOHOLS; AMINO ACID SEQUENCE; CLONING, MOLECULAR; DIMETHYL SULFOXIDE; ENZYME ACTIVATION; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROGEN-ION CONCENTRATION; KINETICS; MOLECULAR SEQUENCE DATA; NITROPHENOLS; ORGANOPHOSPHORUS COMPOUNDS; POLYETHYLENE GLYCOLS; PROTEIN-TYROSINE-PHOSPHATASE; VARIOLA VIRUS; VIRAL PROTEINS;

VARIOLA; VARIOLA MAJOR VIRUS; VARIOLA VIRUS;

EID: 33750451937     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.05.007     Document Type: Article

References (25)

1. Stewart A.J., and Devlin P.M. The history of smallpox vaccine. J. Infect. 19 (2005)
2. Lane H.C., Montagne J.L., and Fauci A.S. Bioterrorism: a clear and present danger. Nat. Med. 7 (2001) 1271-1273
3. Jahrling P.B., Fritz E.A., and Hensley L.E. Countermeasures to the bioterrorist threat of smallpox. Curr. Mol. Med. 5 (2005) 817-826
4. Nafziger S.D. Smallpox. Crit. Care Clin. 21 (2005) 739-746
5. Casey C.G., Iskander J.K., Roper M.H., Mast E.E., Wen X.J., Torok T.J., Chapman L.E., Swerdlow D.L., Morgan J., Heffelfinger J.D., Vitek C., Reef S.E., Hasbrouch L.M., Damon I., Neff L., Vellozzi C., McCauley M., Strikas R.A., and Mootrey G. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 294 (2005) 2734-2743
6. Sejvar J.J., Labutta R.J., Chapman L.E., Grabenstein J.D., Iskander J., and Lane J.M. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA 294 (2005) 2744-2750
7. Harrison S.C., Alberts B., Ehrenfeld E., Enquist L., Fineberg H., McKnight S.L., Moss B., O'Donnell M., Ploegh H., Schmid S.L., Walter K.P., and Theriot J. Discovery of antivirals against smallpox. Proc. Natl. Acad. Sci. USA 101 (2004) 11178-11192
8. Liu K., Lemon B., and Traktman P. The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro. J. Virol. 69 (1995) 7823-7834
9. Wang W.Q., Sun J.P., and Zhang Z.Y. An overview of the protein tyrosine phosphatase superfamily. Curr. Top. Med. Chem. 3 (2003) 739-748
10. Tropea J.E., Cherry S., Nallamsetty S., Bignon C., and Waugh D.S. A generic method for the production of recombinant proteins in Escherichia coli using a dual His6-MBP affinity tag. Methods Mol. Biol. 363 (2006) 1-19
11. Nallamsetty S., Austin B.P., Penrose K.J., and Waugh D.S. Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli. Protein Sci. 14 (2005) 2964-2971
12. Kapust R.B., and Waugh D.S. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 8 (1999) 1668-1674
13. Jeong D.G., Kim S.J., Kim J.H., Son J.H., Park M.R., Lim S.M., Yoon T.S., and Ryu S.E. Trimeric structure of PRL-1 phosphatase reveals an active site conformation and regulation mechanisms. J. Mol. Biol. 345 (2005) 401-413
14. Chen W., Wilborn M., and Rudolph J. Dual-specific Cdc25B phosphatase: in search of the catalytic acid. Biochemistry 39 (2000) 10781-10789
15. Denu J.M., Zhou G., Wu L., Zhao R., Yuvaniyama J., Saper M.A., and Dixon J.E. The purification and characterization of a human dual-specific protein tyrosine phosphatase. J. Biol. Chem. 270 (1995) 3796-3803
16. Kozlov G., Cheng J., Ziomek E., Banville D., Ghering K., and Ekiel I. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3. J. Biol. Chem. 279 (2004) 11882-11889
17. Zhang Z.Y. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Ann. Rev. Pharmacol. Toxicol. 42 (2002) 209-234
18. Ducruet A.P., Vogt A., Wipf P., and Lazo J.S. Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease. Ann. Rev. Pharmacol. Toxicol. 45 (2005) 725-750
19. Hong S.B., Lubben T.H., Dolliver C.M., Petrolonis A.J., Roy R.A., Li Z., Parsons T.F., Li P., Xu H., Reilly R.M., Trevillyan J.M., Nichols A.J., Tummino P.J., and Grant T.G. Expression, purification, and enzymatic characterization of the dual specificity mitogen-activated protein kinase phosphatase, MKP-4. Bioorg. Chem. 33 (2005) 34-44
20. Stephens B.J., Han H., Gokhale V., and Von Hoff D.D. PRL phosphatases as potential molecular targets in cancer. Mol. Cancer Ther. 4 (2005) 1653-1661
21. Derrien M., Punjabi A., Khanna M., Grubisha O., and Traktman P. Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase. J. Virol. (1999) 7287-7296
22. Mercer J., and Traktman P. Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane. J. Virol. 77 (2003) 8857-8871
23. Hoover D.M., and Lubkowski J. DNA works: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res. 30 (2002) e43 10.1093/nar/30.10.e43
24. Hartley J.L., Temple G.F., and Brasch M.A. DNA cloning using in vitro site-specific recombination. Genome Res. 10 (2000) 1788-1795
25. Kapust R.B., Tözsér J., Fox J.D., Anderson D.E., Cherry S., Copeland T.D., and Waugh D.S. Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Eng. 14 (2001) 993-1000